Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Novel heterocyclic CRF antagonists under study at DuPont

Feb. 23, 1999

Ceresine shows positive results in phase II trial in stroke patients

Feb. 22, 1999

Zeneca seeks European approval for Zomig formulation using OraSolv technology

Feb. 22, 1999

Dual 5-HT1A antagonists and 5-HT reuptake inhibitors emerge from research at Vita-Invest

Feb. 22, 1999

Peptidomimetic aspartyl protease inhibitors from Pharmacopeia for AD and malaria

Feb. 22, 1999

Biogen and Inhale enter agreement for pulmonary delivery of Avonex

Feb. 22, 1999

Dopamine D4-selective compounds, therapeutic and diagnostic uses disclosed by Resolution

Feb. 19, 1999

NO synthase inhibition reduces chronic tension headache pain

Feb. 19, 1999

Celgene initiates Canadian clinical trial program for chirally pure form of Ritalin

Feb. 17, 1999

NeoTherapeutics expands Neotrofin clinical trials internationally

Feb. 17, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...